RXRX position history
The shares of Recursion Pharmaceuticals (RXRX) that ARK Investment Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 2,593,836 shares, $60M, 0.14% of portfolio
- 2021 Q4: 2,232,013 shares, $38M, 0.12% of portfolio, Reduce −13.9%
- 2022 Q1: 2,827,163 shares, $20M, 0.08% of portfolio, Add +26.7%
- 2022 Q2: 2,732,087 shares, $17M, 0.10% of portfolio, Reduce −3.4%
- 2022 Q3: 3,359,811 shares, $36M, 0.25% of portfolio, Add +23.0%
- 2022 Q4: 3,099,490 shares, $24M, 0.21% of portfolio, Reduce −7.7%
- 2023 Q1: 3,576,862 shares, $24M, 0.16% of portfolio, Add +15.4%
- 2023 Q2: 4,738,517 shares, $35M, 0.23% of portfolio, Add +32.5%
- 2023 Q3: 6,876,598 shares, $53M, 0.40% of portfolio, Add +45.1%
- 2023 Q4: 20,654,287 shares, $204M, 1.2% of portfolio, Add +200.4%
- 2024 Q1: 24,587,561 shares, $245M, 1.7% of portfolio, Add +19.0%
- 2024 Q2: 28,142,918 shares, $211M, 1.9% of portfolio, Add +14.5%
- 2024 Q3: 32,769,186 shares, $216M, 2.0% of portfolio, Add +16.4%
- 2024 Q4: 32,346,398 shares, $219M, 1.8% of portfolio, Reduce −1.3%
- 2025 Q1: 34,815,502 shares, $184M, 1.8% of portfolio, Add +7.6%
- 2025 Q2: 32,988,631 shares, $167M, 1.2% of portfolio, Reduce −5.2%
- 2025 Q3: 33,545,499 shares, $164M, 0.97% of portfolio, Add +1.7%
- 2025 Q4: 37,316,856 shares, $153M, 1.0% of portfolio, Add +11.2%
- 2026 Q1: 40,212,769 shares, $123M, 0.96% of portfolio, Add +7.8%
- 2026 Q2: 41,337,632 shares, $152M, 0.98% of portfolio, Add +2.8%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|